Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-23

FDA Approved: LEVETIRACETAM — Supplemental Application (Hisun Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for levetiracetam from Hisun Pharmaceuticals USA, Inc., resulting in approval of a generic product under ANDA 207175…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)